Natera CEO on cancer recurrence detection and how it works
CNBC Televisionยท2025-07-08 11:50
Advances in detecting cancer recurrence uh earlier and uh more accurately are transforming how the disease is treated and monitored. One of the companies on the leading edge is Nera. Joining us now, Nera CEO Steve Chapman.The company is celebrating 10 years since going public on the NASDAQ and you got a a real market cap uh at this point and some really good um not only peer-reviewed research, you've got a product. Uh I think you were cash did you have a profit or at least cash flow positive at this point. ...